Iris Z. Uras

1.2k total citations
15 papers, 751 citations indexed

About

Iris Z. Uras is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Iris Z. Uras has authored 15 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Genetics. Recurrent topics in Iris Z. Uras's work include Advanced Breast Cancer Therapies (3 papers), Protein Degradation and Inhibitors (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Iris Z. Uras is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), Protein Degradation and Inhibitors (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Iris Z. Uras collaborates with scholars based in Austria, Germany and United States. Iris Z. Uras's co-authors include Emilio Casanova, Herwig P. Moll, Veronika Sexl, Sebastian Nijman, Markus K. Muellner, Claudia Kerzendorfer, Michal Šmída, Peter Valent, Karoline Kollmann and Jacques Colinge and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Iris Z. Uras

15 papers receiving 745 citations

Peers

Iris Z. Uras

ONCOL

PRM

HEMAT

GENET

Silvia Rita Vitale Italy

Alessandro Perez Italy

Xiaofen Pan China

Grace R. Anderson United States

Hiroshi Sootome Japan

Andrea Ghelli Luserna di Rorà Italy

D. Gandara United States

Alok R. Singh United States

Cathy E. Nolan United States

Vernon T. Phan United States

Silvia Rita Vitale Italy

Iris Z. Uras

429 ×0.9

251 ×1.0

ONCOL

182 ×1.1

PRM

169 ×1.1

HEMAT

163 ×1.2

GENET

Citations per year, relative to Iris Z. Uras Iris Z. Uras (= 1×) peers Silvia Rita Vitale

Countries citing papers authored by Iris Z. Uras

Since Specialization

Citations

This map shows the geographic impact of Iris Z. Uras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Z. Uras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Z. Uras more than expected).

Fields of papers citing papers by Iris Z. Uras

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Z. Uras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Z. Uras. The network helps show where Iris Z. Uras may publish in the future.

Co-authorship network of co-authors of Iris Z. Uras

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Z. Uras. A scholar is included among the top collaborators of Iris Z. Uras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Z. Uras. Iris Z. Uras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Casanova, Emilio, et al.. (2022). Targeted Protein Degradation: Clinical Advances in the Field of Oncology. International Journal of Molecular Sciences. 23(23). 15440–15440. 20 indexed citations

Uras, Iris Z., Veronika Sexl, & Karoline Kollmann. (2020). CDK6 Inhibition: A Novel Approach in AML Management. International Journal of Molecular Sciences. 21(7). 2528–2528. 36 indexed citations

Uras, Iris Z., Herwig P. Moll, & Emilio Casanova. (2020). Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future. International Journal of Molecular Sciences. 21(12). 4325–4325. 103 indexed citations

Uras, Iris Z., et al.. (2020). STAT3: Versatile Functions in Non-Small Cell Lung Cancer. Cancers. 12(5). 1107–1107. 72 indexed citations

Uras, Iris Z., Barbara Maurer, Harini Nivarthi, et al.. (2019). CDK6 coordinates JAK2V617F mutant MPN via NF-κB and apoptotic networks. Blood. 133(15). 1677–1690. 30 indexed citations

Valent, Peter, Guntram Büsche, Igor Theurl, et al.. (2018). Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts. Haematologica. 103(10). 1593–1603. 51 indexed citations

Uras, Iris Z., et al.. (2018). Therapeutic Vulnerabilities in FLT3-Mutant AML Unmasked by Palbociclib. International Journal of Molecular Sciences. 19(12). 3987–3987. 15 indexed citations

Uras, Iris Z., Ruth Scheicher, Karoline Kollmann, et al.. (2017). Cdk6 contributes to cytoskeletal stability in erythroid cells. Haematologica. 102(6). 995–1005. 23 indexed citations

Šmída, Michal, Ferran Fece de la Cruz, Claudia Kerzendorfer, et al.. (2016). MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated. Nature Communications. 7(1). 13701–13701. 33 indexed citations

10.

Uras, Iris Z., Gina Walter, Ruth Scheicher, et al.. (2016). Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6. Blood. 127(23). 2890–2902. 98 indexed citations

11.

Muellner, Markus K., Claudia Kerzendorfer, Iris Z. Uras, et al.. (2014). TOPS: a versatile software tool for statistical analysis and visualization of combinatorial gene-gene and gene-drug interaction screens. BMC Bioinformatics. 15(1). 98–98. 5 indexed citations

12.

Berger, Angelika, Andrea Hoelbl‐Kovacic, Jérôme Bourgeais, et al.. (2013). PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis. Leukemia. 28(3). 629–641. 46 indexed citations

13.

Uras, Iris Z., et al.. (2012). Ubiquitin-Specific Protease 4 Inhibits Mono-Ubiquitination of the Master Growth Factor Signaling Kinase PDK1. PLoS ONE. 7(2). e31003–e31003. 21 indexed citations

14.

Muellner, Markus K., Iris Z. Uras, Bianca V. Gapp, et al.. (2011). A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer. Nature Chemical Biology. 7(11). 787–793. 134 indexed citations

15.

Muellner, Markus K., Ilse Schwarzinger, Mathew A. Sloane, et al.. (2009). Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis. PLoS ONE. 4(12). e8292–e8292. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact